Related Content
Search Google Scholar for:
|
|
Science 17 February 1984: Vol. 223. no. 4637, pp. 703 - 707 DOI: 10.1126/science.6320367
|
|
Articles
Science, Vol 223, Issue 4637, 703-707
Copyright © 1984 by American Association for the Advancement of Science
Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I
SZ Salahuddin,
PD Markham,
SG Lindner,
J Gootenberg,
M Popovic,
H Hemmi,
PS Sarin,
and
RC Gallo
Cell-free conditioned media from human T cells transformed by human T-cell leukemia-lymphoma virus (HTLV-I) were tested for the production of soluble biologically active factors, including several known lymphokines. The cell lines used were established from patients with T-cell leukemia-lymphoma and from human umbilical cord blood and bone marrow leukocytes transformed by HTLV-I in vitro. All of the cell lines liberated constitutively one or more of the 12 biological activities assayed. These included macrophage migration inhibitory factor (MIF), leukocyte migration inhibitory factor (LIF), leukocyte migration enhancing factor (MEF), macrophage activating factor (MAF), differentiation inducing factor (DIF), colony stimulating factor (CSF), eosinophil growth and maturation activity (eos. GMA), fibroblast activating factor (FAF), gamma-interferon and, in rare instances, T-cell growth factor (TCGF). Some cell lines produced interleukin 3 (IL-3), platelet-derived growth factor (PDGF), or B-cell growth factors (BCGF). Such cells should prove useful for the production of lymphokines and as sources of specific messenger RNA's for their genetic cloning.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Roscovitine Inhibits STAT5 Activity and Induces Apoptosis in the Human Leukemia Virus Type 1-Transformed Cell Line MT-2.
- S. Mohapatra, B. Chu, S. Wei, J. Djeu, P. K. Epling-Burnette, T. Loughran, R. Jove, and W. J. Pledger (2003)
Cancer Res.
63, 8523-8530
| Abstract »
| Full Text »
| PDF »
- Exaggerated Messenger RNA Expression of Inflammatory Cytokines in Human T-Cell Lymphotropic Virus Type I--Associated Myelopathy.
- H. Watanabe, T. Nakamura, K. Nagasato, S. Shirabe, K. Ohishi, K. Ichinose, Y. Nishiura, S. Chiyoda, M. Tsujihata, and S. Nagataki (1995)
Arch Neurol
52, 276-280
| Abstract »
| PDF »
- Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection.
- P. Hollsberg and D. A. Hafler (1993)
N. Engl. J. Med.
328, 1173-1182
| Full Text »
- Expression of a zinc finger gene in HTLV-I- and HTLV-II-transformed cells.
- J. Wright, K. Gunter, H Mitsuya, S. Irving, K Kelly, and U Siebenlist (1990)
Science
248, 588-591
| Abstract »
| PDF »
- Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.
- S Nakamura, S. Salahuddin, P Biberfeld, B Ensoli, P. Markham, F Wong-Staal, and R. Gallo (1988)
Science
242, 426-430
| Abstract »
| PDF »
- HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis.
- D. Mann, P DeSantis, G Mark, A Pfeifer, M Newman, N Gibbs, M Popovic, M. Sarngadharan, R. Gallo, J Clark, et al. (1987)
Science
236, 1103-1106
| Abstract »
| PDF »
- Calcitriol Levels in Hypercalcemic Patients With Adult T-Cell Lymphoma.
- R. C. Dodd, C. F. Winkler, M. E. Williams, P. A. Bunn, and T. K. Gray (1986)
Arch Intern Med
146, 1971-1972
| Abstract »
| PDF »
- Evidence for HTLV-I Associated With Mycosis Fungoides and B-Cell Chronic Lymphocytic Leukemia.
- A. Peterman, Myles, S. Staal, Bradley, H. Striecher, J. Schupbach, and L. Resnick (1986)
Arch Dermatol
122, 568-571
| Abstract »
| PDF »
- Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors.
- J Laurence and L Mayer (1984)
Science
225, 66-69
| Abstract »
| PDF »
|
|